ストックスクリーナーアプリを入手
4.39
0.00%
0.00
アフターアワーズ：
4.39
前日終値:
$4.39
開ける：
$4.38
24時間の取引高:
64,510
Relative Volume:
0.54
時価総額：
$218.92M
収益：
$15.33M
当期純損益:
$-40.19M
株価収益率:
-2.5054
EPS:
-1.7522
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-7.38%
1か月 パフォーマンス:
-8.16%
6か月 パフォーマンス:
-15.58%
1年 パフォーマンス:
+5.02%
1日の値動き範囲:
$4.2774
$4.41
1週間の範囲:
$4.2501
$4.80
52週間の値動き範囲:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
名前
Trisalus Life Sciences Inc
セクター
電話
415 336 8917
住所
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.39 | 218.92M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3455 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | 開始されました | Lake Street | Buy |
| 2024-12-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 開始されました | ROTH MKM | Buy |
| 2024-10-25 | 開始されました | Northland Capital | Outperform |
| 2024-09-16 | 開始されました | Oppenheimer | Outperform |
| 2024-05-30 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Trisalus Life Sciences Inc (TLSI) 最新ニュース
Is TriSalus Life Sciences Inc. Equity Warrant still worth holding after the dipMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsWeekly Trade Review & Reliable Trade Execution Plans - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity Warrant2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock a safe haven assetLayoff News & Long-Term Growth Stock Strategies - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedRecession Risk & Weekly Momentum Stock Picks - newser.com
Will TriSalus Life Sciences Inc. stock gain from government policiesJuly 2025 Short Interest & Proven Capital Preservation Methods - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Published on: 2025-11-06 05:42:12 - newser.com
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesQuarterly Market Summary & High Yield Stock Recommendations - fcp.pa.gov.br
Will TriSalus Life Sciences Inc. stock gain from strong economy2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
TriSalus Life Sciences (NASDAQ:TLSI) Shares Down 5.3% – Here’s Why - Defense World
Will breakout in TriSalus Life Sciences Inc. Equity Warrant lead to full recoveryQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
Does TriSalus Life Sciences Inc. show high probability of rebound2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
TriSalus Life Sciences (TLSI) Projected to Post Quarterly Earnings on Thursday - Defense World
Is TriSalus Life Sciences Inc. stock a dividend growth opportunityJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Weekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
How TriSalus Life Sciences Inc. stock performs in stagflation2025 Market Overview & Growth Focused Investment Plans - newser.com
Can TriSalus Life Sciences Inc. Equity Warrant stock beat market expectations this quarterTrade Entry Summary & Consistent Profit Focused Trading Strategies - fcp.pa.gov.br
Automated trading signals detected on TriSalus Life Sciences Inc.Bull Run & Expert-Curated Trade Recommendations - newser.com
Real time social sentiment graph for TriSalus Life Sciences Inc.Market Sentiment Review & Accurate Buy Signal Alerts - newser.com
Will TriSalus Life Sciences Inc. Equity Warrant stock reach Wall Street targetsStock Surge & Short-Term Trading Alerts - fcp.pa.gov.br
Will TriSalus Life Sciences Inc. Equity Warrant stock recover after recent drop2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Can TriSalus Life Sciences Inc. Equity Warrant stock surprise with earnings upsideDollar Strength & Daily Entry Point Alerts - fcp.pa.gov.br
Can TriSalus Life Sciences Inc. stock surprise with earnings upsideDollar Strength & Fast Gain Stock Trading Tips - newser.com
Can machine learning forecast TriSalus Life Sciences Inc. Equity Warrant recoveryJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Published on: 2025-11-05 00:10:13 - newser.com
Has TriSalus Life Sciences Inc. formed a bullish divergencePortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Regression analysis insights on TriSalus Life Sciences Inc. Equity Warrant performanceWeekly Trend Summary & Real-Time Stock Movement Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingQuarterly Profit Summary & High Accuracy Trade Signal Alerts - newser.com
What high frequency data says about TriSalus Life Sciences Inc.Entry Point & High Return Stock Watch Alerts - newser.com
What’s next for TriSalus Life Sciences Inc. stock price2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
Trisalus Life Sciences Inc (TLSI) 財務データ
収益
当期純利益
現金流量
EPS
Trisalus Life Sciences Inc (TLSI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
5.21%
1.43%
大文字化:
|
ボリューム (24 時間):